CollPlant Biotechnologies Ltd.
CLGN
$2.35
-$0.07-2.89%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -7.02M | -6.73M | |
| Total Depreciation and Amortization | -- | -- | 1.10M | 1.11M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | 2.31M | 2.29M | |
| Change in Net Operating Assets | -- | -- | 848.00K | -434.00K | |
| Cash from Operations | -- | -- | -2.76M | -3.76M | |
| Capital Expenditure | -- | -- | -954.00K | -1.01M | |
| Sale of Property, Plant, and Equipment | -- | -- | 68.00K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -270.00K | -76.00K | |
| Cash from Investing | -- | -- | -1.16M | -1.09M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | 1.11M | 1.51M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | 1.11M | 1.51M | |
| Foreign Exchange rate Adjustments | -- | -- | -379.00K | -487.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -3.19M | -3.83M | |